A meta-analysis: Is low-dose computed tomography a superior method for risky lung cancers screening population?

Clinical Respiratory Journal

Volumn 10, Issue 3, 2016, Pages 333-341

  Fu, Cuiping ^a   Liu, Zilong ^a   Zhu, Fen ^a   Li, Shanqun ^a   Jiang, Liyan ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chest X ray; Low dose computed tomography; Lung cancer; Meta analysis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LOW DOSE COMPUTER ASSISTED TOMOGRAPHY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS CHEST X-RAY; MASS SCREENING; MIDDLE AGED; PROGNOSIS; RADIATION DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84962655083     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12222     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62: 10-29.
2. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, etal. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355: 1763-1771.
3. Raz DJ, Zell JA, Ou SH, etal. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132: 193-199.
4. Nawa T, Nakagawa T, Mizoue T, etal. Long-term prognosis of patients with lung cancer detected on low-dose chest computed tomography screening. Lung Cancer. 2012;75: 197-202.
5. Garg K, Keith RL, Byers T, etal. Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results. Radiology. 2002;225: 506-510.
6. Bach PB, Jett JR, Pastorino U, etal. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297: 953-961.
7. Field JK, Duffy SW. Lung cancer screening: the way forward. Br J Cancer. 2008;99: 557-562.
8. Smith RA, Field JK, Duffy SW. A global approach to cancer-screening trials. Lancet Oncol. 2008;9: 908-909.
9. Tockman MS, Mulshine JL. Sputum screening by quantitative microscopy: a new dawn for detection of lung cancer? Mayo Clin Proc. 1997;72: 788-790.
10. Prorok PC, Andriole GL, Bresalier RS, etal. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer screening trial. Control Clin Trials. 2000;21: 273S-309S.
11. Payne PW, Sebo TJ, Doudkine A, etal. Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study. Mayo Clin Proc. 1997;72: 697-704.
12. Palmisano WA, Divine KK, Saccomanno G, etal. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60: 5954-5958.
13. Miozzo M, Sozzi G, Musso K, etal. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients. Cancer Res. 1996;56: 2285-2288.
14. Melamed MR. Lung cancer screening results in the National Cancer Institute New York study. Cancer. 2000;89: 2356-2362.
15. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 1994;54: 1634-1637.
16. Kubik A, Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer. 1986;57: 2427-2437.
17. Fontana RS, Sanderson DR, Woolner LB, etal. Lung cancer screening: the Mayo program. J Occup Med. 1986;28: 746-750.
18. Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax. 1968;23: 414-420.
19. van Klaveren RJ, Habbema JDF, Pedersen JH, etal. Lung cancer screening by low-dose spiral computed tomography. Eur Respir J. 2001;18: 857-866.
20. Gopal M, Abdullah SE, Grady JJ, Goodwin JS. Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol. 2010;5: 1233-1239.
21. Couraud S, Cortot AB, Greillier L, etal. From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF). Ann Oncol. 2013;24: 586-597.
22. Munden RF, Godoy MC. Lung cancer screening: state of the art. J Surg Oncol. 2013;108: 270-274.
23. Humphrey LL, Deffebach M, Pappas M, etal. Screening for lung cancer with low-dose computed tomography: a systematic review to update the u.s. Preventive services task force recommendation. Ann Intern Med. 2013;159: 411-420.
24. National Lung Screening Trial Research Team, Aberle DR, Adams AM, etal. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365: 395-409.
25. Saghir Z, Dirksen A, Ashraf H, etal. CT screening for lung cancer brings forward early disease. The randomised danish lung cancer screening trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67: 296-301.
26. Pedersen JH, Ashraf H, Dirksen A, etal. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round. J Thorac Oncol. 2009;4: 608-614.
27. Infante M, Cavuto S, Lutman FR, etal. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180: 445-453.
28. Blanchon T, Brechot JM, Grenier PA, etal. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007;58: 50-58.
29. Lopes Pegna A, Picozzi G, Mascalchi M, etal. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer. 2009;64: 34-40.
30. Gohagan JK, Marcus PM, Fagerstrom RM, etal. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 2005;47: 9-15.
31. Gohagan J, Marcus P, Fagerstrom R, etal. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004;126: 114-121.
32. Pastorino U, Rossi M, Rosato V, etal. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21: 308-315.
33. van Klaveren RJ, Oudkerk M, Prokop M, etal. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361: 2221-2229.
34. National Lung Screening Trial Research Team, Aberle DR, Adams AM, etal. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst. 2010;102: 1771-1779.
35. Henschke CI. Early lung cancer action project: overall design and findings from baseline screening. Cancer. 2000;89: 2474-2482.
36. de Torres JP, Casanova C, Marin JM, etal. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study. Respir Med. 2013;107: 702-707.
37. Baldwin DR, Duffy SW, Wald NJ, etal. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax. 2011;66: 308-313.
38. Shmueli A, Fraifeld S, Peretz T, etal. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the israeli experience. Value Health. 2013;16: 922-931.
39. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012;157: 571-573. [PMID: 22893040].